(Q51554328)

English

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

scientific article published in August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

type-1 diabetes

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

0 references

author name string

L Chaillous

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

H Lefèvre

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

C Thivolet

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

C Boitard

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

N Lahlou

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

C Atlan-Gepner

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

B Bouhanick

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

A Mogenet

8

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

M Nicolino

9

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

J C Carel

10

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

P Lecomte

11

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

R Maréchaud

12

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

P Bougnères

13

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

B Charbonnel

14

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

P Saï

15

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

356

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

9229

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

545-549

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral tolerance for the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Active suppression of diabetes after oral administration of insulin is determined by antigen dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: down-regulation of KLH-reactive precursor-cell frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with early remission of type I diabetes in children treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902579-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02579-4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10950231

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51554328&oldid=1655497605"